- Home
- TMHC vs ALKS Comparison
TMHC vs ALKS Comparison
Compare TMHC & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMHC
- ALKS
- Stock Information
- Founded
- TMHC 1936
- ALKS 1987
- Country
- TMHC United States
- ALKS Ireland
- Employees
- TMHC N/A
- ALKS N/A
- Industry
- TMHC Homebuilding
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- TMHC Consumer Discretionary
- ALKS Health Care
- Exchange
- TMHC Nasdaq
- ALKS Nasdaq
- Market Cap
- TMHC 5.9B
- ALKS 4.9B
- IPO Year
- TMHC 2013
- ALKS 1991
- Fundamental
- Price
- TMHC $69.66
- ALKS $26.97
- Analyst Decision
- TMHC Strong Buy
- ALKS Strong Buy
- Analyst Count
- TMHC 8
- ALKS 14
- Target Price
- TMHC $79.38
- ALKS $41.29
- AVG Volume (30 Days)
- TMHC 1.1M
- ALKS 2.0M
- Earning Date
- TMHC 10-22-2025
- ALKS 10-23-2025
- Dividend Yield
- TMHC N/A
- ALKS N/A
- EPS Growth
- TMHC 28.80
- ALKS 21.99
- EPS
- TMHC 8.67
- ALKS 2.08
- Revenue
- TMHC $8,403,420,000.00
- ALKS $1,505,296,000.00
- Revenue This Year
- TMHC N/A
- ALKS N/A
- Revenue Next Year
- TMHC N/A
- ALKS $1.66
- P/E Ratio
- TMHC $8.03
- ALKS $12.99
- Revenue Growth
- TMHC 13.77
- ALKS N/A
- 52 Week Low
- TMHC $51.90
- ALKS $25.17
- 52 Week High
- TMHC $75.49
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- TMHC 56.13
- ALKS 41.58
- Support Level
- TMHC $68.98
- ALKS $26.70
- Resistance Level
- TMHC $71.27
- ALKS $28.65
- Average True Range (ATR)
- TMHC 1.41
- ALKS 1.11
- MACD
- TMHC 0.02
- ALKS -0.27
- Stochastic Oscillator
- TMHC 55.35
- ALKS 27.61
About TMHC Taylor Morrison Home Corporation
Taylor Morrison Home Corp is an American residential construction company engaged in residential homebuilding and the development of lifestyle communities. It designs, builds, and sells single and multi-family detached and attached homes in traditionally high growth markets for entry level, move-up, and resort lifestyle buyers. The company has four reportable segments: East, Central, West, and Financial Services. The majority of the company's revenue is derived from its West Segment.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.